Newton Charles W.
CIK 1866219
Transactions on file
10
Open-market buys
1
Win rate (buys)
100%
1 scored
Avg % since filing (buys)
+2350.0%
Tickers traded
Recent activity
| Filed | Txn date | Issuer | Roles | Code | Shares | Value | % since Filing | Filing |
|---|---|---|---|---|---|---|---|---|
| 2026-06-09 | 2026-06-05 | CHRS Coherus Oncology, Inc. | Grant | 30,000 | $0.00 | — | open → | |
| 2026-04-28 | 2026-04-25 | NVAX NOVAVAX INC | Director | Exer. | 9,520 | $0.00 | — | open → |
| 2025-02-26 | 2025-02-10 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Grant | 112,500 | $0.00 | — | open → |
| 2025-03-18 | 2025-03-17 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Buy | 200,000 | $112.0K | +2350.0% | open → |
| 2025-05-15 | 2025-05-13 | TSVT 2seventy bio, Inc. | Director | Disp. | 17,092 | — | — | open → |
| 2025-05-15 | 2025-05-13 | TSVT 2seventy bio, Inc. | Director | U | 5,533 | — | — | open → |
| 2025-08-13 | 2025-08-11 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Sale | 131 | $1.4K | +30.3% | open → |
| 2025-08-13 | 2025-08-12 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Sale | 136 | $1.4K | +32.7% | open → |
| 2025-08-22 | 2025-08-21 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Sale | 1,453 | $15.3K | +30.2% | open → |
| 2025-08-22 | 2025-08-20 | LYEL Lyell Immunopharma, Inc. | Officer Chief Financial Officer | Grant | 8,000 | $0.00 | — | open → |
